Oramed Raises $13M In Private Placement

December 26, 2013 | Israeli biomed company Oramed Pharmaceuticals, which is developing an insulin pill to replace injection-based treatments of diabetes, has raised $13 million in a private placement on Nasdaq. “Globes” reports that the funds were raised from Special Situation Fund and Sabby Capital Healthcare.